Research Library · Comparison

AOD-9604 vs Semaglutide

A side-by-side research comparison — classification, molecular weight, mechanism, and how each is verified. For laboratory research use only.

AOD-9604 1,815.1 g/molSemaglutide 4,113.58 g/molResearch Use Only

01At a Glance

AOD-9604Semaglutide
ClassificationMetabolicMetabolic
Molecular weight1,815.1 g/mol4,113.58 g/mol
Also known asAOD9604GLP-1 receptor agonist
Purity spec≥99% HPLC≥99% HPLC
VerificationMZ Biolabs · 5-panelMZ Biolabs · 5-panel
UseResearch Use OnlyResearch Use Only

02How They Differ

AOD-9604

A modified growth-hormone fragment studied for lipolytic and fat-metabolism pathways.

AOD-9604 is a synthetic modified fragment of human growth hormone corresponding to the C-terminal residues 176-191 with a tyrosine modification. Research focuses on its lipolytic activity and effects on fat metabolism.

Semaglutide

A long-acting GLP-1 receptor agonist studied for incretin signaling and glucose-metabolism research.

Semaglutide is a long-acting synthetic analog of glucagon-like peptide-1, acting as an agonist of the GLP-1 receptor. Research models study its role in incretin signaling, glucose-dependent insulin secretion, and energy-homeostasis pathways.

Research framing only · No human-use claims

03Selecting for a Research Model

Because AOD-9604 and Semaglutide are both metabolic research compounds, they are frequently evaluated against one another. Selection depends entirely on the research question, model system, and endpoints being measured. Both compounds are supplied strictly for in-vitro and laboratory research and are not for human or veterinary use.

Whichever you select, every Ethos Bio lot is verified the same way — a five-point independent panel with a batch-specific Certificate of Analysis. See how we test →

04FAQ

What is the difference between AOD-9604 and Semaglutide?

AOD-9604 is a metabolic research compound — A modified growth-hormone fragment studied for lipolytic and fat-metabolism pathways. Semaglutide is also studied within the metabolic area — A long-acting GLP-1 receptor agonist studied for incretin signaling and glucose-metabolism research. They differ in molecular weight (AOD-9604: 1,815.1 g/mol; Semaglutide: 4,113.58 g/mol) and primary mechanism. Both are supplied for laboratory research use only.

What are the molecular weights of AOD-9604 and Semaglutide?

AOD-9604 has a molecular weight of 1,815.1 g/mol. Semaglutide has a molecular weight of 4,113.58 g/mol.

Are AOD-9604 and Semaglutide in the same research class?

Yes — both AOD-9604 and Semaglutide are categorized as Metabolic research compounds, which is why they are often compared.

How are AOD-9604 and Semaglutide tested?

Both are analyzed by an independent third-party laboratory (MZ Biolabs, Arizona) on a five-point panel — HPLC purity, mass-spectrometry identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis provided per lot.

05Explore

AOD-9604 Product → Semaglutide Product →

AOD-9604 monograph · Semaglutide monograph